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Background: Outcome reporting bias has received widespread recognition and been considered to pose two threats
to the validity of clinical decision making because they overestimate the effect of treatments or distort the results of
trials. However, the problem of outcome-reporting bias has not been systematically studied among randomized clinical
trials of acupuncture. Our objectives were to evaluate the consistency between the registered records and subsequent
publications with respect to outcomes and other data as well as to determine whether outcome-reporting bias favors
significant primary outcomes.
Methods: A systematic search of 15 registries was conducted from their inception to January 2014 to identify
randomized clinical trials on acupuncture for which the status was listed as ‘completed.’ The subsequent publications
were retrieved by searching PubMed and three Chinese databases. Basic characteristics and the registration information
were extracted from the registered records and publications. We performed comparisons regarding primary outcomes
and other data between the registered records and subsequent publications to assess the consistency and selective
outcome reporting.
Results: Eighty-eight trials on acupuncture with 96 published reports were identified. Only 19.3% (17/88) were
registered before the start of the trial, suggesting prospective registration. The trial registration number was
unavailable in 36 published reports (37.5%). A comparison of registered and published primary outcomes could
be conducted in 71 publications (74.0%), and the inconsistency of the primary outcomes was identified in 45.1%
(32 of 71); 71.4% (15 of 21) had a discrepancy that favored statistically significant primary outcomes, while 28.6%
(6 of 21) favored nonsignificant primary outcomes. Furthermore, the other inconsistencies between the registry records
and subsequent publications involved the inclusion criteria (54.7%), exclusion criteria (47.9%) and controls (22.9%).
Conclusions: We find that prospective registration for randomized clinical trials on acupuncture is insufficient, selective
outcome reporting is prevalent, and the change of primary outcomes is intended to favor statistical significance. These
discrepancies in outcome reporting may lead to biased and misleading results of randomized clinical trials on
acupuncture. To ensure publication of reliable and unbiased results, further promotion and implementation of
trial registration are still needed.
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Outcome reporting bias in a clinical study is defined as
the selection of a subset of the original variables re-
corded on the basis of the significance and direction of
the results [1]. It distorts the results of trials and leads
to a reduction in the strength of evidence for conduct-
ing systematic reviews and developing clinical practice
guidelines [2-5].
Prospectively trial registration in international clinical
trial registries before participant enrollment is one of the
main ways to potentially reduce selective outcome reporting
and further outcome reporting bias [6,7]. The International
Committee of Medical Journal Editors (ICMJE) announced
a policy of requiring investigators to register clinical trials in
a clinical trial registry before participant enrollment as a pre-
requisite for publication in 2004. This policy took effect in
2005 and is applicable to any clinical trial beginning enroll-
ment after 1 July 2005 [8]. The World Health Organization
formally established the International Clinical Trials Registry
Platform (ICTRP; http://www.who.int/ictrp/en/) in 2004 to
push for clinical trial registration. Furthermore, several peer-
reviewed journals, such as The Lancet and Trials, publish
study protocols to achieve transparency regarding perform-
ance and reporting of clinical trials.
Outcome reporting bias has received much attention.
Many empirical studies evaluating the consistency con-
cerning outcomes between the protocol or trial registry
entry of randomized clinical trials (RCTs) and subsequent
publications have demonstrated that outcome reporting
bias is prevalent and favors statistically significant results
[9-16]. A recent study focusing on RCTs of traditional
Chinese medicine (TCM) showed discrepancies were
identified in primary outcomes (29%) and safety report-
ing (28%) when comparing registered records with their
subsequent publications [17]. However, the problem of
outcome-reporting bias has not been systematically stud-
ied among RCTs of acupuncture.
Our objectives were to evaluate the consistency between
the registered records and subsequent publications with
respect to outcomes and other data as well as to deter-
mine whether outcome-reporting bias favors significant
primary outcomes.Methods
Inclusion criteria
We included RCTs on acupuncture alone or in combin-
ation with other interventions that were registered in trial
registries. The current status was limited to ‘completed’ in
the registered records. Acupuncture was defined as a col-
lection of procedures involving penetration of the skin
with needles manipulated by the hands or by electrical
stimulation to stimulate certain points on the body [18].
We excluded phase 1 trials.Search and selection of trials
A systematic search of 15 major international trial regis-
tries was conducted using the search terms “acupuncture”
or “electroacupuncture” or “auriculotherapy” from their
inception to January 2014. Trial registries included the
Australian New Zealand Clinical Trials Registry (ANZCTR),
Brazilian Clinical Trials Registry (ReBec), Chinese Clinical
Trial Register (ChiCTR), Clinical Research Information
Service (CRiS) public of Korea (KCT), ClinicalTrials.
gov, Clinical Trials Registry-India (CTRI), Cuban Public
Registry of Clinical Trials (RPCEC), EU Clinical Trials
Register (EU-CTR), German Clinical Trials Register (DRKS),
International Standard Randomized Controlled Trial
Number Register (ISRCTN), Iranian Registry of Clinical
Trials (IRCT), Japan Primary Registries Network (JPRN),
Pan African Clinical Trial Registry (PACTR), the
Netherlands National Trial Register (NTR), and Sri
Lanka Clinical Trials Registry (SLCTR). If trials were
listed as ‘completed’ in the registered records, the full
texts of subsequently published articles were retrieved
by searching PubMed without a language limit and
three Chinese electronic bibliographic databases including
China National Knowledge Infrastructure (http://www.cnki.
net), Chinese Biomedical Database (http://sinomed.
imicams.ac.cn/index.jsp), and Chinese VIP Information
(http://vip.hbdlib.cn/index.asp) using the trial registration
number, registered trial title, and investigator name. Iden-
tified articles were checked against the target registered re-
cords to determine whether they were a correct match.
For each trial, all published articles reporting the final re-
sults were included. Abstracts and reports of preliminary
results were excluded.
Data extraction
Two authors (Su CX, Han M, Ren J, or Li WY) inde-
pendently extracted data using a standardized, piloted
data extraction form. The form was modified based on
the previous research [17]. We collected the following
information reported in trial registries and published ar-
ticles: trial design, sample size, participants and diseases/
conditions, interventions, controls, primary and second-
ary outcomes along with the time frame of assessment,
inclusion and exclusion criteria, and funding. For each
registered trial, we also extracted the date registered, start
and end dates of participant enrollment/the trial, sponsors,
and country of origin. Publication year and language,
journal name, registered number, and P values for all the
outcomes were also extracted from each subsequently
published report. The 2013 impact factor of journals
where registered trials were published was sought. ‘Instruc-
tions for authors’ of the included journals was checked for
whether the registration of the trial and reporting of the
trial’s registration number were required in the published
report. The “history of changes” in the registries was
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had been changed since the initial registration. Conditions
were classified according to International Statistical Classi-
fication of Diseases and Related Health Problems, 10th
Revision (ICD-10) (http://apps.who.int/classifications/icd10/
browse/2010/en; last accessed on 27 January 2014).Data analyses
Methodological quality of registered records and subse-
quent publications was assessed independently by two
authors (Su CX, Ren J, or Li WY) using the Cochrane
Collaboration risk of bias tool, which included gener-
ation of the allocation sequence, allocation concealment,
blinding, incomplete outcome reporting, selective out-
come reporting, and other risk of bias [19]. Other risk of
bias was assessed based on the estimated sample size,
explicit inclusion and exclusion criteria, and the risk of
funding bias.
Two authors (Su CX, Ren J, or Li WY) evaluated the
consistency and selective outcome reporting regarding
the trial design, methodology, and outcomes from the
registered records and subsequently published articles.
The disagreements were resolved by consensus with a
third party (Liu JP). We defined inconsistency as “when
the items in the trial registry were not the same as those
in the subsequent publications” [17]. If over 20% discrepancy
was identified between the sample size in the registered tri-
als and published reports, we considered it inconsistent [19].
Selective outcome reporting was defined as “when the pri-
mary outcome specified in the published articles was differ-
ent, or changed from those defined in the trial registry, or
the timing of assessment of the registered and published pri-
mary outcomes differed” [20,21].
A discrepancy was considered to favor statistically sig-
nificant results (P < 0.05) if a new statistically significant
primary outcome was described in the published articles
or if a nonsignificant primary outcome was defined as a
nonprimary outcome in the published articles [10,21].
Data were presented as counts, percentage and frequency
for categorical variables. Proportions were compared by the
χ2 test. P < 0.05 was considered statistically significant. SAS
version 9.1 (SAS Institute Inc, Cary, NC) was applied for
statistical analysis.Results
Of 860 registered acupuncture trials retrieved, 399 indi-
cated their current status as ‘completed’. After excluding
160 registered trials because of duplicates or being
non-RCTs, non-acupuncture and phase I, we searched
subsequent publications for 88 of the 239 registered
trials (36.8%). The 88 trials produced 96 publications
reporting study outcomes, among which all publications
were in English (Figure 1).Of the 88 included trial protocols, 65 (73.9%; 72 articles)
were from western countries; 23 (26.1%; 24 articles) were
from eastern countries, of which only 7 were performed in
mainland China (excluding Hong Kong and Taiwan). The
included trial protocols were registered in eight registries
and the majority was registered in either clinicaltrials.gov
(43/88, 48.9%) or ISRCTN (36/88, 40.9%). The first trial
was registered in 2001. Only 19.3% (17/88) were registered
before the start of the trial, suggesting prospective regis-
tration. The remaining 71 trials were registered after the
study began, even after the completion of the study. The
proportion of retrospective registration was similar for
trials from western countries (54/65, 83.1%) and eastern
countries (17/23, 73.9%; P = 0.33). When comparing trials
starting before 1 July 2005 (36/40, 90.0%), the proportion
of retrospective registration was higher than that in trials
starting after 1 July 2005 (35/48, 72.9%; P = 0.04).
Ninety-six articles were published in 49 journals from
1997 to 2014 (Figure 2). Seven (7.3%) were published in
alternative and complementary journals. Sixteen (16.7%)
were published in journals whose 2013 impact factor was
high than 10 (Additional file 1: Table S1). Twenty-seven
journals (48 articles; 50.0%) provided guidance on trial
registration and reporting of the registration number in
their instructions for the author. Of 36 articles (37.5%)
without description of the registration number, 50.0%
(18/36) were published in journals requiring the reporting
of the registration number.
The characteristics of included articles are presented in
Table 1. The majority of the included articles were parallel
group (92, 95.8%), single center (55, 57.3%), two armed
(59, 61.5%), and sponsored by a university, government
or hospital (77, 80.2%). The five most frequent conditions
based on ICD-10 were musculoskeletal (26.1%), nervous
(19.3%), mental and behavioral disorders (17.0%), re-
spiratory conditions (5.7%) and neoplasms (5.7%; Table 2).
Manual acupuncture and electro-acupuncture were re-
ported in 80 (83.3%) and 16 (16.7%) articles, respectively.
Interventions in the treatment groups involved acupunc-
ture alone in 70 (72.9%) articles or acupuncture combined
with other interventions in 26 (27.1%) articles. There was
considerable variation in the control group. Fifty-one arti-
cles (53.1%) applied sham/placebo acupuncture; other com-
monly used controls involved western medicine (26.0%), no
intervention (9.4%) and non-pharmaceutical interventions
(9.4%). A clear description of the primary outcome and sec-
ondary outcome was provided in 71 (74.0%) and 60 articles
(62.5%), respectively. However, safety and health-economic
outcomes were only reported in 38 (39.6%) and 5 articles
(5.2%), respectively.
Seventy-five subsequent publications (78.1%) provided
detailed information on the generation of allocation
sequences with the most use of a computer random
number generator. Fifty-eight articles (60.4%) provided
Figure 1 Flow diagram of study selection.
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providing information on blinding, 37 applied single blind-
ing, 28 double blinding, and 4 triple blinding. However,
only 3.4% (3/88), 2.3% (2/88) and 61.4% (54/88) of the
registered records provided information on the gener-
ation of an allocation sequence, allocation conceal-
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Figure 2 Number of included randomized clinical trials on acupunctureporting occurred in 33 (34.4%) articles. The sample
size of the 96 articles ranged from 10 (pilot trials) to
960, with the majority (88.6%) of sample sizes between
20 and 500 per trial (Additional file 2: Table S2). Only
34 articles (35.4%) carried out a sample size calcula-
tion. All registered records lacked information on sam-
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n (%) = 96 n (%) = 72 n (%) = 24
Study registration
After the trial began 76 (79.2) 58 (80.6) 18 (75.0)
Before the trial began 20 (20.8) 14 (19.4) 6 (25.0)
Study design
Parallel 92 (95.8) 68 (94.4) 24 (100.0)
Crossover 4 (4.2) 4 (5.6) 0 (0.0)
Study center
Single 55 (57.3) 40 (55.6) 15 (62.5)
Multiple 41 (42.7) 32 (44.4) 9 (37.5)
Number of arms
Two 59 (61.5) 46 (63.9) 13 (54.2)
Three 29 (30.2) 22 (30.6) 7 (29.2)
Four 8 (8.3) 4 (5.5) 4 (16.7)
Funding source
No funding 14 (14.6) 13 (18.1) 1 (4.2)
University 37 (38.5) 25 (34.7) 12 (50.0)
Hospital 13 (13.5) 7 (9.7) 6 (25.0)
Government 27 (28.1) 23 (31.9) 4 (16.7)
Private non-profit 1 (1.0) 1 (1.4) 0 (0.0)
Other source 4 (4.2) 3 (4.2) 1 (4.2)
Type of acupuncture
Manual acupuncture 80 (83.3) 64 (88.9) 16 (66.7)
Electro-acupuncture 16 (16.7) 8 (11.1) 8 (33.3)
Intervention
Acupuncture used alone 70 (72.9) 51 (70.8) 19 (79.2)
Acupuncture combined with
other interventions*
26 (27.1) 21 (29.2) 5 (20.8)
Control†
Placebo/sham-acupuncture# 51 (53.1) 37 (51.4) 14 (58.3)
Western medicine 25 (26.0) 18 (25.0) 7 (29.2)
No intervention 9 (9.4) 7 (9.7) 2 (8.3)
Non-pharmaceutical
interventions
9 (9.4) 9 (12.5) 0 (0.0)
Conventional therapy 7 (7.3) 7 (9.7) 0 (0.0)
Acupuncture 6 (6.3) 4 (5.6) 2 (8.3)
Waiting list 4 (4.2) 3 (4.2) 1 (4.2)
Chinese herbal medicine 1 (1.0) 0 (0.0) 1 (4.2)
Specified primary outcome 71 (74.0) 50 (69.4) 21 (87.5)
Specified secondary outcome 60 (62.5) 42 (58.3) 18 (75.0)
Safety come 38 (39.6) 24 (33.3) 12 (50.0)
Health-economic outcome 5 (5.2) 5 (6.9) 0 (0.0)
Random sequence generation
Random number table 4 (4.2) 4 (5.6) 0 (0.0)
Table 1 Characteristics of the included articles (Continued)
Computer random number
generator
69 (71.9) 46 (63.9) 23 (95.8)
Minimization 2 (2.1) 2 (2.8) 0 (0.0)
Not reported 21 (21.9) 20 (27.8) 1 (4.2)
Allocation concealment
Opaque sealed envelope 23 (24.0) 19 (26.4) 4 (16.7)
Central allocation 28 (29.2) 24 (33.3) 4 (16.7)
Sealed/opaque envelope 7 (7.3) 5 (7.0) 2 (8.3)
Not reported 38 (39.6) 24 (33.3) 14 (58.3)
Blinding
Single-blinded 37 (38.5) 26 (36.1) 11 (45.8)
Blinding to participants 21 (21.9) 16 (22.2) 5 (20.8)
Blinding to personnel 3 (3.1) 2 (2.8) 1 (4.2)
Blinding to outcome assessor 13 (13.5) 8 (11.1) 5 (20.8)
Double-blinded 28 (29.2) 19 (26.4) 9 (37.5)
Blinding to participants and
personnel
10 (10.4) 9 (12.5) 1 (4.2)
Blinding to participants and
outcome assessors
18 (18.8) 10 (13.9) 8 (33.3)
Blinding to personnel and
outcome assessors
0 (0.0) 0 (0.0) 0 (0.0)
Triple-blinded 4 (4.2) 3 (4.2) 1 (4.2)
Open 15 (15.6) 11 (15.3) 4 (16.7)
Not reported 12 (12.5) 11 (15.3) 1 (4.2)
Incomplete outcome reporting 33 (34.4) 28 (38.9) 5 (20.8)
Sample size estimation 34 (35.4) 22 (30.6) 12 (50.0)
Explicit inclusion criteria 94 (97.9) 71 (98.6) 23 (95.8)
Explicit exclusion criteria 82 (85.4) 60 (83.3) 22 (91.7)
Note: *Other interventions included western medicine in 18 articles,
conventional therapy in 2 articles, non-pharmaceutical interventions in 4
articles, Chinese herbal medicine in 1 article and placebo drug in 1 article.
†Thirty-seven (38.5%) articles reported three or four arms in one study.
#Placebo acupuncture was conducted by using Streitberger placebo needles,
which have a blunt tip. The needle retracted inside its handle when its tip
touched the skin rather than penetrating the skin. Sham-acupuncture refers to
nonspecific points, mock acupuncture/electro-acupuncture, mock transcutaneous
electrical nerve stimulation, shallow needling and minimal acupuncture
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and exclusion criteria.
A comparison of registered and published primary out-
comes was impossible in 25 articles (26.0%) because out-
comes were not specified as primary outcome or secondary
outcome in the subsequent publications. Of the remaining
71 articles, the primary outcomes of 32 articles (45.1%)
were inconsistent with those specified in registered records
(Table 3). The discrepancies involved a registered primary
outcome omitted in the published article (22/71, 31.0%), an
absent primary outcome in the registry defined as a primary
outcome in the published article (9/71, 12.7%), a published
primary outcome registered as a secondary outcome (1/71,
1.4%), a registered primary outcome defined as a secondary
Table 2 Conditions based on the ICD-10 classification treated by acupuncture
Disease/conditions (ICD-10 codes) No. of
trials (%)
Western countries Eastern countries
n (%) n (%)
M00-M99 Diseases of the musculoskeletal system and connective tissue 23 (26.1) 19 4
G00-G99 Diseases of the nervous system 17 (19.3) 12 5
F00-F99 Mental and behavioral disorders 15 (17.0) 10 5
J00-J99 Diseases of the respiratory system 5 (5.7) 3 2
C00-D48 Neoplasms 5 (5.7) 5 0
E00-E90 Endocrine, nutritional and metabolic diseases 4 (4.5) 3 1
N00-N99 Diseases of the genitourinary system 4 (4.5) 1 3
O00-O99 Pregnancy, childbirth and the puerperium 4 (4.5) 4 0
K00-K93 Diseases of the digestive system 3 (3.4) 3 0
R00-R99 Symptoms, signs and abnormal clinical and laboratory findings,
not elsewhere classified
3 (3.4) 3 0
A00-B99 Certain infectious and parasitic diseases 1 (1.1) 1 0
H60-H95 Diseases of the ear and mastoid process 1 (1.1) 0 1
Health 1 (1.1) 0 1
L00-L99 Diseases of the skin and subcutaneous tissue 1 (1.1) 0 1
S00-T98 Injury, poisoning and certain other consequences of external causes 1 (1.1) 1 0
Total 88 (100) 65 (73.9) 23 (26.1)
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ent timing of assessment of the primary outcome in the
published article and the registry (12/71, 16.9%). Fourteen
articles had two reasons for the difference in primary out-
comes, five articles had three reasons for the difference in
primary outcomes, and one article had four reasons for the
difference in primary outcomes. This inconsistency was alsoTable 3 Proportion of discrepancies in the specified primary o
on acupuncture and discrepancies favoring statistically signif
Discrepancy in published articles relative to registered trials
Articles with different primary outcomes in the trial registration and th
article
Registered primary outcome omitted in published articles
An absent primary outcome in the registry defined in the published article
A published primary outcome registered as a secondary outcome
A registered primary outcome defined as a secondary outcome in the publis
Different timing of assessment of the primary outcome




aFourteen articles had two reasons for the difference in primary outcome; five articl
four reasons for the difference in primary outcome.
bEleven articles had two reasons for the difference in primary outcome; five articles
cThree article had two reasons for the difference in primary outcome; one article ha
from western countries: P = 0.07.
dA discrepancy in primary outcome was said to favor statistically significant results
article or when a statistically nonsignificant primary outcome was defined as a nonaddressed in 13 articles published in journals requiring trial
registration; the proportion of inconsistency was lower than
those published in journals not requiring trial registration
[13 of 38 (34.2%) vs. 19 of 33 (57.6%); P = 0.048]. Five of 13
articles were published in a high-impact-factor journal
(IF > 10). When comparing trials from western countries
with trials from eastern countries, the proportion of thisutcomes between registered trials and published articles
icant results
Total Western countries Eastern countries
n = 71 (%) n = 50 (%) n = 21 (%)
e published 32 a(45.1) 26 b(52.0) 6 c(28.6)
22 (31.0) 18 (36.0) 4 (19.0)
9 (12.7) 7 (14.0) 2 (9.5)
1 (1.4) 1 (2.0) 0 (0.0)
hed article 15 (21.1) 13 (26.0) 2 (9.5)
12 (16.9) 8 (16.0) 4 (19.0)
ltsd 32 26 6
15 (46.9) 13 (50.0) 2 (33.3)
6 (18.8) 4 (15.4) 2 (33.3)
11 (34.3) 9 (34.6) 2 (33.3)
es had three reasons for the difference in primary outcome; one article had
had three reasons for the difference in primary outcome.
d four reasons for the difference in primary outcome. Compared with articles
when a new, statistically significant primary outcome was introduced in the
primary outcome in the published article.
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(28.6%) vs. 26 of 50 (52.0%); P = 0.07].
Furthermore, 81.7% (138/169) registered primary out-
comes were clinically relevant outcomes (patient-centered
outcomes). Among them, 22.5% (31/138) clinically rele-
vant outcomes from the 15 registered trial records were
missing in the final publications, and 9.4% (13/138) clinic-
ally relevant outcomes from 11 registered records had
been changed from the original primary outcome to the
secondary outcome in the publications.
Of the 32 articles with inconsistency in primary out-
comes between the published article and registry, the
influence of this inconsistency could only be evaluated
in 65.6% (21 of 32). Among them, 15 of 21 (71.4%) had
discrepancies that favored statistically significant primary
outcomes, while 6 of 21 (28.6%) favored nonsignificant
primary outcomes.
Comparing the 88 registered records with their 96
subsequent publications, the other inconsistencies were
identified in the inclusion criteria (54.7%), exclusion
criteria (47.9%) and controls (22.9%) (Table 4).
The ‘history of changes’ was available in 44 registered
trial records (44/88, 50.0%) from six registries. After the
initial registration, a change of primary outcomes was
identified in seven registered trial records (7/88, 8.0%),
and 14 registered trial records (14/88, 15.9%) had the fol-
lowing changes: changes of study arms, sample size, blind-
ing, controls and inclusion/exclusion criteria.Table 4 Comparison of methodological components between
randomized clinical trials on acupuncture








Generation of allocation sequences5 0.0
Allocation concealment6 0.0
Blinding of participants7 16.7
Blinding of personnel8 18.0
Blinding of outcome assessors9 22.8
1A comparison was available in 57 articles, of which 38 were from western countrie
2A comparison was available in 96 articles, of which 72 were from western countrie
3A comparison was available in 95 articles, of which 71 were from western countrie
4A comparison was available in 71 articles, of which 48 were from western countrie
5A comparison was available in 3 articles, of which 1 were from western countries.
6A comparison was available in 2 articles, of which 1 were from western countries.
7A comparison was available in 60 articles, of which 40 were from western countrie
8A comparison was available in 61 articles, of which 41 were from western countrie
9A comparison was available in 57 articles, of which 37 were from western countrieDiscussion
To assess outcome reporting bias, we identified a sample
of 96 articles of acupuncture trials. Among them, 33.3%
(32/96) articles showed clear discrepancies between the
registered primary outcomes and the published primary
outcomes. The inconsistency was addressed in 13 articles
published in those journals requiring trial registration, and
5 of 13 articles were published in high-impact-factor jour-
nals. Furthermore, the other inconsistencies between the
registry records and subsequent publications involved the
inclusion criteria (54.7%), exclusion criteria (47.9%) and
control interventions (22.9%). Selective outcome reporting
has received widespread recognition. In previous studies,
inconsistencies of primary outcomes between the regis-
tered records and corresponding publications in Western
medicine varied from 18% and 49% [22-24].
Prospective trial registration provides a good opportun-
ity for the editors and peer reviewers to evaluate outcome
reporting bias and other deviations between the registered
records and subsequent publications. However, we found
some evidence of selective outcome reporting in 45.1% of
the articles and other discrepancies between the published
articles and the registered records in terms of inclusion/
exclusion criteria, blinding, sample size, etc. These results
highlight that editors and peer reviewers may not cross-
check the consistency between the submitted manuscript
and the registered records to identify any discrepancies,
and to further limit an outcome reporting bias, evenregistered records and subsequent publications of
Inconsistency rate of trials
from western countries (%)
Inconsistency rate of trials
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A previous qualitative study of editors’ views on trial regis-
tration and publication bias showed that 11 of 15 journals
required trial registration as a requisite for publication,
but most editors seldom check whether the trial is ad-
equately registered, and some editors did not even enforce
trial registration [25].
This study also demonstrated that the trial registration
number was unavailable in 36 published reports. Our find-
ing is consistent with previous research that also indicated
poor reporting of the registration number in published re-
ports [26]. This may hamper editors and peer reviewers in
accessing the registration records and to further assess the
selective outcome reporting [23]. Accordingly, an accurate
trial registration number should be provided in the publi-
cations. Then, the editors and peer reviewers should sys-
tematically check the consistency between the submitted
manuscript and registration records, especially regarding
the adequate reporting of important items such as the pri-
mary outcome.
As highlighted in our results, which confirmed the
earlier findings [20,21], changes in the primary outcomes,
as specified in the publications, from those specified in the
registration records favored statistically significant over
nonsignificant results. Such changes pose a threat to
the reliability of results and further preclude clinicians
and policymakers from making correct clinical decisions.
Possible reasons for the discrepancies include the following:
a preference for primary outcomes with statistical signifi-
cance to increase the opportunity of the trial for publication
and to support the use of the treatment [23,27].
The main purpose of prospective registration of clinical
trials is to enhance the transparency of the clinical trial
and provide access to the trial protocol [6,8]. If the trial is
retrospectively registered, the meaning of the trial registra-
tion is lost; if information in registries is insufficiently
detailed, with some items not registered or inadequately
registered, this information will be useless for compar-
ing the consistency between the registered records and
subsequent publications. Therefore, adequate registra-
tion is of great significance to safeguard against publication
bias [21]. However, our study showed that the proportion
of prospective registered trials was still considerably low
even with the introduction of the ICJME initiative policy
implementation; registered information differed widely
among trials; essential information such as randomization
and blinding was poorly registered in the registries. Hence,
the principal investigators and sponsors have the responsi-
bility to adequately register a clinical trial. Furthermore,
greater efforts should be made to improve the quality con-
trol processes of trial registries [21].
Although more than half of journals have required
trial registration following the ICMJE guidelines, some
journals use ambiguous language (i.e., encouragement ofthe trial registration) in their instruction to authors. We
found similar results in previous studies [22,28]. A lack
of submission guideline clarity might contribute to
explaining inadequate trial registration and poor reporting
of registration numbers.
We acknowledge that our study has several potential lim-
itations. First, only trials indicated as having a ‘completed’
status in registries were searched for publications. A recent
study indicated that many authors seemed to forget to
change the status of their study to being completed,
even among published studies [29]. Therefore, those trials
in the registries where the status was not listed as
‘completed’ but that had been completed may not have
been searched for and included in this study, which
may have caused a bias.
Second, only PubMed and three Chinese databases were
searched for published reports on acupuncture; therefore,
some trials that have been published and included in other
databases may have been missed.
Conclusions
Although trial registration is now the rule, we find that
prospective registration for RCTs on acupuncture is in-
sufficient, selective outcome reporting is prevalent, and
the change of primary outcomes is intended to favor stat-
istical significance. These discrepancies in outcome report-
ing may lead to biased and misleading results of RCTs on
acupuncture. To ensure publication of reliable and un-
biased results, further promotion and implementation of
trial registration are still needed.
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